Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: Association with degree of DNA aneuploidy

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 237-245

  Giaretti, Walter ^a   Monaco, Roberto ^b   Pujic, Natalija ^a   Rapallo, Anna ^a   Nigro, Stefano ^a   Geido, Elio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; DIPLOIDY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; ONCOGENE K RAS; PRIORITY JOURNAL;

ADENOCARCINOMA; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FLOW CYTOMETRY; GENES, RAS; HUMANS; LYMPHATIC METASTASIS; PLOIDIES; POINT MUTATION; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0029987629     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Hartwell L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992, 71:543-546
2. Hartwell L, Kastan MB: Cell cycle control and cancer. Science 1994, 266:1821-1828
3. Kaufmann WK: Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev 1995, 14:31-41
4. Tlsty TD: Cell cycle control and genomic instability. Cancer Met Rev 1995, 14:1-2
5. Cairns J: The origin of human cancer. Nature 1981, 289:353-357
6. Bishop JM: The molecular genetics of cancer. Science 1987, 235:305-311
7. Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989, 49:3713-3721
8. Nowell PC: The clonal evolution of tumor cell populations: acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 1976, 194:23-28
9. Heim S, Mitelman F: Chromosomal abnormalities in specific disorders: solid tumors. Cancer Cytogenetics. Edited by S Heim, F Mitelman. New York, Alan R Liss, 1987, p 227
10. Nowell PC: Molecular events in tumor development. N Engl J Med 1988, 319:575-577
11. Nowell PC: Biology of disease: cancer, chromosomes, and genes. Lab Invest 1992, 66:407-417
12. Yunis JJ, Soreng AL: Constitutive fragile sites and cancer. Science 1984, 226:1199-1204
13. Sutherland GR, Simmers RN: No statistical association between common fragile sites and nonrandom chromosomal breakpoints in cancer cells. Cancer Genet Cytogenet 1988, 31:9-15
14. Volpe JPG: Genetic instability of cancer: why a metastatic tumor is unstable and benign tumor is stable. Cancer Genet Cytogenet 1988, 34:125-134
15. Muto T, Bussey HJR, Morson BC: The evolution of cancer of the colon and rectum. Cancer 1975, 36: 2251-2270
16. Sugarbaker JP, Gunderson LL, Wittes RE: Colorectal cancer. Cancer: Principles and Practices of Oncology, ed 2. Edited by VT DeVita, S Hellman, SA Rosenberg. Philadelphia, JB Lippincott, 1985, pp 800-803
17. Bos JL, Fearon ER, Hamilton SR, Verlaan de Vries M, van Boom JH, van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 1987, 327:293-297
18. Solomon E, Voss R, Hall V, Bodmer WF, Jass JR, Jeffreys AJ, Lucibello FC, Patel I, Rider SH: Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987, 328: 616-619
19. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW: Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988, 319:533-537
20. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert BAM, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectaltumor development. N Engl J Med 1988, 319:525-532
21. Burmer GC, Loeb LA: Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 1989, 86:2403-2407
22. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R: Allelotype of colorectal carcinomas. Science 1989, 244:207-211
23. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
24. Fishel R, Lescoe MK, Rao MSR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993, 75:1027-1038
25. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, Guan XY, Zhang J, Meltzer PS, Yu JW, Kao FT, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin JP, Järvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75:1215-1225
26. Nicolaides NN, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994, 371:75-80
27. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987, 327: 298-303
28. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689
29. Benhattar J, Losi L, Chaubert P, Givel JC, Costa J: Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 1993, 104:1044-1048
30. Fearon ER: K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer. J Natl Cancer Inst 1993, 85:1978-1980
31. McLellan EA, Owen RA, Stepniewska KA, Sheffield JP, Lemoine NR: High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 1993, 34:392-396
32. Yamashita N, Minamoto T, Ochia A, Onda M, Esumi H: Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995, 108:434-440
33. Pretlow TP: Aberrant crypt foci and K-ras mutations earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology 1995, 108: 600-603
34. Hiddemann W, Von Bossewitz DB, Kleinemeier HJ, Schulte-Brochterbeck E, Hauss J, Lingemann B, Büchner T, Grundmann E: DNA stemline heterogeneity in colorectal cancer. Cancer 1986, 58:258-263
35. Fischbach W, Zidianakis Z, Lüke G, Kirchner T, Mössner J: DNA mapping of colorectal neoplasms: a flow cytometric study of DNA abnormalities and proliferation. Gastroenterology 1993, 105:1126-1133
36. Giaretti W: A model of DNA aneuploidization and evolution in colorectal cancer. Lab Invest 1994, 71:904-910
37. Giaretti W, Pujic N, Rapallo A, Nigro S, Di Vinci A, Geido E, Risio M: K-ras2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas. Gastroenterology 1995, 108:1040-1047
38. Giaretti W, Sciallero S, Bruno S, Geido E, Aste H, Di Vinci A: DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas. Cytometry 1988, 9:238-244
39. Sciallero S, Bruno S, Di Vinci A, Geido E, Aste H, Giaretti W: Flow cytometric DNA ploidy in colorectal adenomas and family history of colorectal cancer. Cancer 1988, 61:114-120
40. Giaretti W, Santi L: Tumor progression by DNA flow cytometry in human colorectal cancer. Int J Cancer 1990, 45:597-603
41. Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954, 139:846-851
42. Morson BC, Sobin LH: Histological typing of intestinal tumors. International Histological Classification of Tumors. Geneva, World Health Organization 1976, p 14
43. Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RJ, Witzig TE, Rabinovitch PS: Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993, 14:486-491
44. Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della Porta G, Barbacid M: Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 1984, 223:661-664
45. Verlaan-de-Vries M, Bogaard ME, van del Elst H, van Boom JH, van der Eb AJ, Bos JL: A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 1986, 50: 313-320
46. Current Protocols in Molecular Biology. New York, Green Publishing Association and Wiley-Interscience, John Wiley and Sons, 1988
47. Fleiss JL: Statistical Methods for Rates and Proportions. ed 2. New York, John Wiley and Sons, 1981
48. Rubio CA: Atypical mitosis in colorectal adenomas. Pathol Res Pract 1991, 187:508-513
49. Hagag N, Diamond L, Palermo R, Lyubsky S: High expression of ras p21 correlates with increased rate of abnormal mitosis in NIH3T3 cells. Oncogene 1990, 5:1481-1489
50. Barbacid M: ras genes. Annu Rev Biochem 1987, 56: 779-827
51. McCormick F: ras GTPase activating protein: signal transmitter and signal terminator. Cell 1989, 56:5-8
52. Krengel U, Schlichting I, Scherer A, Schumann R, Frech M, John J, Kabsch W, Pai EF, Wittinghofer A: Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell 1990, 62:539-548
53. Bos JL: p21ras: an oncoprotein functioning in growth factor-induced signal transduction. Eur J Cancer 1995, 31A:1051-1054
54. Topal MD: DNA repair, oncogenes, and carcinogenesis. Carcinogenesis 1988, 9:691-696
55. Capella G, Cronauer-Mitra S, Peinado MA, Perucho M: Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 1991, 93:125-131
56. Vousden KH, Bos JL, Marshall CJ, Phillips DH: Mutations activating human c-Ha-ras1 proto-oncogene (Hras1) induced by chemical carcinogens and depurination. Proc Natl Acad Sci USA 1986, 83:1222-1226
57. Brown K, Buchmann A, Balmain A: Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc Natl Acad Sci USA 1990, 87:538-542
58. Urosevic N, Krtolica K, Skaro-Milic A, Knezevic-Usaj S, Dujic A: Prevalence of G-to-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia. Int J Cancer 1993, 54:249-254
59. Loeb LA: Endogenous carcinogenesis: molecular oncology into the twenty-first century: presidential address. Cancer Res 1989, 49:5489-5496
60. Suchy B, Zietz C, Rabes HM: K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int J Cancer 1992, 52:30-33
61. Laurent-Puig P, Olschwang S, Delattre O, Remvikos Y, Asselain B, Melot T, Validire P, Muleris M, Girodet J, Salmon RJ, Thomas G: Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992, 102:1136-1141
62. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA: Genotypic classification of colorectal adenocarcinomas: biologic behavior correlates with K-ras2 mutation type. Cancer 1993, 71:3827-3838
63. Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G: K-ras mutation in colorectal cancer: relations to patient age, sex, and tumour location. Br J Cancer 1994, 69:367-371
64. Moerkerk P, Arends JW, van Driel M, de Bruïne A, de Goeij A, ten Kate J: Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994, 54:3376-3378